Regeneron Gets Emergency U.S. Clearance for Covid-19 Therapy

Published November 21, 2020

Regeneron Pharmaceuticals Inc.’s antibody cocktail received an emergency-use authorization from U.S. drug regulators for treatment of early Covid-19 symptoms, adding to the expanding arsenal of therapies available to physicians at a time when the virus is surging.